20Indexed trials
mesh condition
Fragile X Syndrome
Intelligence
Fragile X Syndrome intelligence: 20 indexed trials, 4 recruiting studies, 15 sponsors across 7 countries.
4Recruiting
15Sponsors
7Countries
Leading sponsors
Tetra Discovery Partners31 recruiting
Seaside Therapeutics, Inc.30 recruiting
Université de Sherbrooke21 recruiting
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud10 recruiting
Institute for Neurodegenerative Disorders10 recruiting
Marinus Pharmaceuticals10 recruiting
Nova Mentis Life Science Corp10 recruiting
Alcobra Ltd.10 recruiting
Rush University Medical Center11 recruiting
University Hospital, Tours10 recruiting
University of Alberta10 recruiting
University of California, Davis10 recruiting
Geographic activity
United States13trials
Canada3trials
Spain2trials
Italy1trials
Israel1trials
France1trials
Belgium1trials
Leading interventions
Placebo Medication2trials
Metformin2trials
STX2092trials
Biological samples1trials
CBD Oral Solution (eCBD system Target)1trials
CTH1201trials
CTH120 placebo hard capsules1trials
Cooperative Parent Mediated Therapy" (CPMT)1trials
Functional Behavioral Training (FBT)1trials
Ganaxolone1trials
Lovastatin, then Minocycline/Lovastatin1trials
MG01CI extended-release tablet1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.